Interleukin-35 inhibits endothelial cell activation by suppressing MAPK-AP-1 Pathway

Journal of Biological Chemistry

Volumn 290, Issue 31, 2015, Pages 19307-19318

  Sha, Xiaojin ^a   Meng, Shu ^a   Li, Xinyuan ^a   Xi, Hang ^a   Maddaloni, Massimo ^b   Pascual, David W ^b   Shan, Huimin ^a   Jiang, Xiaohua ^a   Wang, Hong ^a   Yang, Xiao Feng ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION;

ANTI-INFLAMMATORIES; CYTOKINES; VASCULAR ENDOTHELIAL CELLS; VASCULAR ENDOTHELIUM;

ENDOTHELIAL CELLS;

CHEMOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 27; INTERLEUKIN 35; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; VASCULAR CELL ADHESION MOLECULE 1; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CELL ACTIVATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE ADHERENCE; LUNG LAVAGE; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ADULT; AGED; ANIMAL; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; CELL ADHESION; CELL CULTURE; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SEPSIS; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADULT; AGED; ANIMALS; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INTERLEUKINS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MIDDLE AGED; SEPSIS; TRANSCRIPTION FACTOR AP-1; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 84940480277     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.663286     Document Type: Article

References (38)

1. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M. R. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310
2. Wood, K. A., and Angus, D. C. (2004) Pharmacoeconomic implications of new therapies in sepsis. PharmacoEconomics 22, 895-906
3. Stoll, L. L., Denning, G. M., and Weintraub, N. L. (2004) Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 2227-2236
4. Xiong, Z., Yan, Y., Song, J., Fang, P., Yin, Y., Yang, Y., Cowan, A., Wang, H., and Yang, X. F. (2009) Expression of TCTP antisense in CD25(high) regulatory T cells aggravates cuff-injured vascular inflammation. Atherosclerosis 203, 401-408
5. Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A. K., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., Flavell, R. A., Hansson, G. K., Klatzmann, D., Tedgui, A., and Mallat, Z. (2006) Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180
6. Yang, W. Y., Shao, Y., Lopez-Pastrana, J., Mai, J., Wang, H., and Yang, X. F. (2015) Pathological conditions re-shape physiological Tregs into pathological Tregs. Burns Trauma 3, 1-11
7. Libby, P., Ridker, P. M., and Hansson, G. K. (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325
8. Chowienczyk, P. J., Watts, G. F., Cockcroft, J. R., and Ritter, J. M. (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430-1432
9. He, S., Li, M., Ma, X., Lin, J., and Li, D. (2010) CD4 -CD25 -Foxp3 - regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 30, 2621-2630
10. Wang, R. X., Yu, C. R., Mahdi, R. M., and Egwuagu, C. E. (2012) Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells. J. Biol. Chem. 287, 36012-36021
11. Shen, P., Roch, T., Lampropoulou, V., O'Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., Li, R., Jouneau, L., Boudinot, P., Wilantri, S., Sakwa, I., Miyazaki, Y., Leech, M. D., McPherson, R. C., Wirtz, S., Neurath, M., Hoehlig, K., Meinl, E., Grützkau, A., Grün, J. R., Horn, K., Kühl, A. A., Dörner, T., Bar-Or, A., Kaufmann, S. H., Anderton, S. M., and Fillatreau, S. (2014) IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366-370
12. Dixon, K. O., Van Der Kooij, S. W., Vignali, D. A., and Van Kooten, C. (2015) Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members. Eur. J. Immunol. 45, 1736-1747
13. Choi, J., Leung, P. S., Bowlus, C., and Gershwin, M. E. (2015) IL-35 and autoimmunity: A comprehensive perspective. Clin. Rev. Allergy Immunol. 10.1007/s12016-015-8468-9
14. Whitehead, G. S., Wilson, R. H., Nakano, K., Burch, L. H., Nakano, H., and Cook, D. N. (2012) IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 129, 207-215.e1-5, 10.1016/j.jaci.2011.08.009
15. Kochetkova, I., Golden, S., Holderness, K., Callis, G., and Pascual, D. W. (2010) IL-35 stimulation of CD39 - regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 184, 7144-7153
16. Niedbala, W., Wei, X. Q., Cai, B., Hueber, A. J., Leung, B. P., McInnes, I. B., and Liew, F. Y. (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37, 3021-3029
17. Li, X., Mai, J., Virtue, A., Yin, Y., Gong, R., Sha, X., Gutchigian, S., Frisch, A., Hodge, I., Jiang, X., Wang, H., and Yang, X. F. (2012) IL-35 is a novel responsive anti-inflammatory cytokine: A new system of categorizing antiinflammatory cytokines. PLoS One 7, e33628
18. Vignali, D. A., and Kuchroo, V. K. (2012) IL-12 family cytokines: Immunological playmakers. Nat. Immunol. 13, 722-728
19. Collison, L. W., Delgoffe, G. M., Guy, C. S., Vignali, K. M., Chaturvedi, V., Fairweather, D., Satoskar, A. R., Garcia, K. C., Hunter, C. A., Drake, C. G., Murray, P. J., and Vignali, D. A. (2012) The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290-299
20. Howard, M., Muchamuel, T., Andrade, S., and Menon, S. (1993) Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208
21. Yang, X. F., Yin, Y., and Wang, H. (2008) Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov. Today Ther. Strateg. 5, 125-142
22. Mannam, P., Zhang, X., Shan, P., Zhang, Y., Shinn, A. S., Zhang, Y., and Lee, P. J. (2013) Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury. J. Immunol. 190, 1264-1275
23. Shaulian, E., and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-136
24. Iademarco, M. F., McQuillan, J. J., Rosen, G. D., and Dean, D. C. (1992) Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267, 16323-16329
25. Jersmann, H. P., Hii, C. S., Ferrante, J. V., and Ferrante, A. (2001) Bacterial lipopolysaccharide and tumor necrosis factor - synergistically increase expression of human endothelial adhesion molecules through activation of NF -B and p38 mitogen-activated protein kinase signaling pathways. Infect. Immun. 69, 1273-1279
26. Rawlings, J. S., Rosler, K. M., and Harrison, D. A. (2004) The JAK/STAT signaling pathway. J. Cell Sci. 117, 1281-1283
27. Wirtz, S., Tubbe, I., Galle, P. R., Schild, H. J., Birkenbach, M., Blumberg, R. S., and Neurath, M. F. (2006) Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 203, 1875-1881
28. Koltsova, E. K., Kim, G., Lloyd, K. M., Saris, C. J., Von Vietinghoff, S., Kronenberg, M., and Ley, K. (2012) Interleukin-27 receptor limits atherosclerosis in Ldlr -/ - mice. Circ. Res. 111, 1274-1285
29. Guzzo, C., Ayer, A., Basta, S., Banfield, B. W., and Gee, K. (2012) IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes. J. Immunol. 188, 864-873
30. Kim, K. D., Zhao, J., Auh, S., Yang, X., Du, P., Tang, H., and Fu, Y. X. (2007) Adaptive immune cells temper initial innate responses. Nat. Med. 13, 1248-1252
31. Tedgui, A., and Mallat, Z. (2001) Anti-inflammatory mechanisms in the vascular wall. Circ. Res. 88, 877-887
32. Henke, P. K., DeBrunye, L. A., Strieter, R. M., Bromberg, J. S., Prince, M., Kadell, A. M., Sarkar, M., Londy, F., and Wakefield, T. W. (2000) Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J. Immunol. 164, 2131-2141
33. Jackson, S. M., Parhami, F., Xi, X. P., Berliner, J. A., Hsueh, W. A., Law, R. E., and Demer, L. L. (1999) Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler. Thromb. Vasc. Biol. 19, 2094-2104
34. Tsoyi, K., Kim, W. S., Kim, Y. M., Kim, H. J., Seo, H. G., Lee, J. H., Yun-Choi, H. S., and Chang, K. C. (2009) Upregulation of PTEN by CKD712, a synthetic tetrahydroisoquinoline alkaloid, selectively inhibits lipopolysaccharide-induced VCAM-1 but not ICAM-1 expression in human endothelial cells. Atherosclerosis 207, 412-419
35. Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J. C., Connelly, P. W., and Milstone, D. S. (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107, 1255-1262
36. Collins, R. G., Velji, R., Guevara, N. V., Hicks, M. J., Chan, L., and Beaudet, A. L. (2000) P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein Edeficient mice. J. Exp. Med. 191, 189-194
37. Taga, T., and Kishimoto, T. (1997) Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15, 797-819
38. Wisnoski, N., Chung, C. S., Chen, Y., Huang, X., and Ayala, A. (2007) The contribution of CD4 - CD25 - T-regulatory-cells to immune suppression in sepsis. Shock 27, 251-257